Livia Schiavinato Eberlin, Ph.D.
Professor of Surgery
Positions
- Professor of Surgery
-
Division of Surgical Oncology
ÌÇÐÄÊÓÆµ of Medicine
- Vice Chair for Research
-
Michael E. DeBakey Department of Surgery
- Translational Research and Innovations Endowed Chair
-
ÌÇÐÄÊÓÆµ of Medicine
- Director, Translational and Innovations Research
-
Michael E. DeBakey Department of Surgery
- Co-Director, INSTINCT
-
Michael E. DeBakey Department of Surgery
Interdisciplinary Surgical Technology and Innovation Center
Addresses
- Alkek Building for Biomedical Research (Lab)
-
Room R414
Houston, TX, 77030
United States
Education
- BS from State University of Campinas
- Campinas, São Paulo, Brazil
- Chemistry
- PhD from Purdue University
- West Lafayette, Indiana
- Analytical Chemistry
- Research Fellowship at Stanford University
- Stanford, California
Honors & Awards
- Norman Hackerman Award in Chemical Research
- The Welch Foundation
- Nick Valvano Translational Research Grant
- V Foundation for Cancer Research
- 2025 Biemann Medal
- American Society for Mass Spectrometry
Professional Interests
- Mass spectrometry
- Cancer diagnosis
- Medical devices
Professional Statement
Dr. Eberlin received a bachelor’s in chemistry from the State University of Campinas in Sao Paulo, Brazil, and a Ph.D. in analytical chemistry from Purdue University. She went on to complete a research fellowship in the Department of Chemistry at Stanford University in California. Prior to joining ÌÇÐÄÊÓÆµ of Medicine, Dr. Eberlin was an assistant professor in the Departments of Chemistry, Oncology and Diagnostic Medicine at The University of Texas at Austin.
Dr. Eberlin and her research team are the recipients of many honors and awards for their scientific research, including a NIH/NCI K99/R00 Pathway to Independence Award, a Forbes 30 under 30 listing in the ÌÇÐÄÊÓÆµ category, a Moore Inventor Fellowship, and a MacArthur Fellowship in 2018. Her research group is funded by grants from the NIH, CPRIT and other research foundations. Additionally, Dr. Eberlin has published more than 80 peer-reviewed research articles in top-rated journals such as PNAS, Science Translational Medicine, Nature Communications, Cancer Research, and Clinical Chemistry.
Dr. Eberlin’s research program centers around the development and application of novel mass spectrometry technologies in health-related research, with a particular focus on disease detection and diagnosis to improve patient care and clinical outcomes.
Dr. Eberlin and her research team are the recipients of many honors and awards for their scientific research, including a NIH/NCI K99/R00 Pathway to Independence Award, a Forbes 30 under 30 listing in the ÌÇÐÄÊÓÆµ category, a Moore Inventor Fellowship, and a MacArthur Fellowship in 2018. Her research group is funded by grants from the NIH, CPRIT and other research foundations. Additionally, Dr. Eberlin has published more than 80 peer-reviewed research articles in top-rated journals such as PNAS, Science Translational Medicine, Nature Communications, Cancer Research, and Clinical Chemistry.
Dr. Eberlin’s research program centers around the development and application of novel mass spectrometry technologies in health-related research, with a particular focus on disease detection and diagnosis to improve patient care and clinical outcomes.
Selected Publications
-
M. E. King, J. Zhang, J. Q. Lin, K. Y. Garza, R. J. DeHoog, C. L. Feider, A. Bensussan, M. Sans, A. Krieger, S. Badal, M. F. Keating, S. Woody, S. Dhingra, W. Yu, C. Pirko, K. A. Brahmbhatt, G. Van Buren, W. E. Fisher, J. Suliburk, and L. S. Eberlin. " " PNAS. ;
-
J. Zhang, M. Sans, R. J. DeHoog, K. Y. Garza, M. E. King, C. L. Feider, A. Bensussan, M. F. Keating, et al.. " " Clinical Chemistry. ;
-
A. V. Bensussan, J. Lin, C. Guo, R. Katz, S. Krishnamurthy, E. Cressman, and L. S. Eberlin. " " Clinical Chemistry. ;
-
M. F. Keating, J. Zhang, C. L. Feider, S. Retailleau, R. Reid, A. Antaris, B. Hart, G. Tan, T. E. Milner, K. Miller, and L. S. Eberlin. " " Analytical Chemistry. ;
to edit your profile